Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

Not Applicable

Completed

• Conditions: Obsessive Compulsive Disorder

• Registration Number: NCT00234689
• Lead Sponsor: Sheba Medical Center

Brief Summary

Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD

Detailed Description

Not available

Study Timeline

• Study Start: 2002-01
• Primary Completion: 2004-12
• Study Completion: 2004-12
• Study First Submitted: 2005-10-06
• Study First Submitted QC: 2005-10-06
• Study First Posted: 2005-10-07
• Status Verified: 2008-01
• Last Update Submitted: 2008-01-28
• Last Update Posted: 2008-01-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Diagnosis of OCD
• Treatment with SSRI for at least 10 weeks with no response

Exclusion Criteria

• Suffering from any medical condition
• treatment with opiates
• chronic use of drugs
• Hepatitis or other liver related diseases
• Incapability to sign an informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (1)

Chaim Sheba Medical Center; 🇮🇱 Ramat-Gan, Israel